DONGGUAN, GUANGDONG, CHINA, January 22, 2026 /EINPresswire.com/ — As global healthcare systems increasingly emphasize ...
A gene therapy candidate extended survival in a mouse model of SMARD1, supporting its testing in a clinical trial for this ...
Zacks Investment Research on MSN
Keros Therapeutics vs. Dyne: Which DMD biotech has more upside?
Keros Therapeutics KROS is a clinical-stage biopharmaceutical company developing innovative therapies for patients with ...
Adding neuromuscular electrical stimulation to physiotherapy boosts functional performance in hospitalized patients with ...
Discusses 3-Year Topline Results From EMBARK Phase 3 Trial of ELEVIDYS in Duchenne Muscular Dystrophy January 26, ...
Sarepta Therapeutics' gene therapy for Duchenne muscular dystrophy slowed disease progression and showed sustained benefit ...
New York, Jan. 26, 2026 (GLOBE NEWSWIRE) -- In recognition of Rare Disease Day on February 28, the Muscular Dystrophy Association (MDA) is sharing powerful community stories throughout the month that ...
Comics as a literary form probably originated in the 1830s with the Swiss cartoonist Rodolphe Töpffer (1799–1846). He created heroes who were found in interconnected stories depicted through drawings ...
When I am teaching around the country, participants often tease me about being a paid spokesperson for Champaign-Urbana,” ...
After JP Morgan, the company is focusing on getting ready to submit a biologics license application to the FDA for miv-cel in ...
MOUNTAIN VIEW , CA, UNITED STATES, January 7, 2026 /EINPresswire.com/ -- Renaissance Healthcare for Women, led by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results